Martin J. Lohse is at the Laboratory of Molecular Biology, University of Munich, 82152 Martinsried, Germany; the Institute of Pharmacology and Toxicology, University of Würzburg, 97078 Würzburg, Germany.
Trends Cardiovasc Med. 1995 Mar-Apr;5(2):63-8. doi: 10.1016/1050-1738(94)00034-4.
The family of G-protein-coupled receptors includes many well-studied members, such as the adrenergic and the muscarinic acetylcholine receptors. These receptors are regulated by multiple mechanisms that serve to adapt their expression and their function to a rapidly changing environment. One of the most intriguing and important regulatory mechanisms involves the phosphorylation of such receptors by a set of specific kinases, termed the G-protein-coupled receptor kinases (GRKs). This phosphorylation is followed by binding of specific arrestin proteins to the phosphorylated receptors, which uncouples the receptors from their G proteins and thus causes a loss of receptor function. Several isoforms of the GRKs and the arrestins are expressed in the heart. They may be involved in the loss of receptor function in response to drugs. Furthermore, increased expression of one of the GRKs, β-adrenergic receptor kinase-1, has been found in failing hearts, and its increased activity may contribute to the loss of β-adrenergic receptor function in heart failure.
G 蛋白偶联受体家族包括许多研究得很好的成员,如肾上腺素能受体和毒蕈碱型乙酰胆碱受体。这些受体受多种机制调节,这些机制有助于使它们的表达和功能适应快速变化的环境。其中最有趣和最重要的调节机制之一涉及一组特定激酶(称为 G 蛋白偶联受体激酶 (GRK))对这些受体的磷酸化。这种磷酸化之后,特定的 arrestin 蛋白与磷酸化的受体结合,使受体与其 G 蛋白解耦联,从而导致受体功能丧失。心脏中表达多种 GRK 和 arrestin 的同工型。它们可能参与了对药物的受体功能丧失的反应。此外,在衰竭的心脏中发现一种 GRK(β-肾上腺素能受体激酶-1)的表达增加,其活性增加可能导致心力衰竭中 β-肾上腺素能受体功能的丧失。